Atlas Trials

Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection

Clinical trial NCT04366245 · COMPLETED

Trial details

NCT number
NCT04366245
Sponsor
Andalusian Network for Design and Translation of Advanced Therapies
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
SARS-CoV 2
Start date
2020-04-23
Primary completion
2020-12-30
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.